Introduction Trauma remains one of the most pervasive public-health challenges worldwide, affecting millions across all age groups and cultures. Whether caused by violence, disaster, systemic injustice, or chronic stress, trauma often leads to long-term psychological consequences such as anxiety disorders, depression, and post-traumatic stress disorder (PTSD). As traditional treatment models struggle to meet global needs, […]
The legal landscape surrounding ibogaine continues to evolve rapidly as scientific evidence accumulates and attitudes toward psychedelic medicine shift globally. As we approach 2026, the regulation of this naturally occurring alkaloid varies dramatically across jurisdictions, creating a patchwork of legal frameworks that reflects diverse approaches to balancing therapeutic potential against safety concerns. Understanding where ibogaine […]
The scientific investigation of ibogaine as a potential intervention for addiction has evolved from anecdotal reports and observational studies to more rigorous clinical research over the past three decades. While the compound remains in a complex regulatory position across much of the world, preventing large-scale randomized controlled trials in many jurisdictions, a growing body of […]
Ibogaine, a naturally occurring psychoactive compound found in the root bark of the African shrub Tabernanthe iboga, has captured the attention of neuroscientists and addiction researchers over the past several decades. While its traditional use in spiritual ceremonies spans centuries in Central African cultures, modern scientific investigation has revealed a complex neurobiological profile that distinguishes […]